Saluda Medical featured in Nature Journal
Biomedicine: Move over, morphine James Mitchell Crow Nature 535, S4–S6 (14 July 2016) Published online 13 July 2016 Link here.
Saluda Medical – Aussie innovation gives hope to back pain sufferers
/in Portfolio Companies, Saluda MedicalOctober 14, 2015: 9NEWS spoke exclusively to the first patient to undergo the new treatment that is giving hope to sufferers of back pain. Read more at http://www.9news.com.au/national/2015/10/14/19/04/aussie-innovation-gives-hope-to-back-pain-sufferers#b0dfx4DwJTTVgPDM.99
Saluda spinal implant for pain relief heralded as ‘breakthrough’
/in Portfolio Companies, Saluda MedicalHarriet Alexander Sydney Morning Herald. Published: October 14, 2015 6:34PM Every minute of the night and day, for decades, Jaswir Grewal was in pain. The constant ache in his back forced him to leave his jobs as a mechanic and banana grower. The pain troubled his sleep, made him irritable with his wife, depressed about his […]
BIOSCIENCE MANAGERS $5M CORNERSTONE INVESTMENT IN SALUDA MEDICAL
/in BioSciences Managers, Portfolio Companies, Saluda MedicalPotential breakthrough treatment for chronic pain Part of $10m capital raising BioScience Managers achieved a 24.7% IRR in its previous fund – top decile performance of international private equity and venture capital fund managers. 20 February 2015, Melbourne, Australia: Leading healthcare fund manager BioScience Managers has invested $5 million in novel chronic pain treatment company Saluda […]
Saluda announces Series B funding
/in Portfolio Companies, Saluda MedicalSaluda Medical secures $10 million in new financing New funding secured for Saluda Medical is set to open the next chapter in commercialising breakthrough treatment of chronic pain. Link here. Friday, 20 February 2015: Saluda Medical has today announced that it has received $10 million in Series B financing bringing a breakthrough treatment for chronic pain – […]